CHD Chemicals Q1 Results: Net loss widens 20% YoY to ₹12.3 lakh
CHD Chemicals reported a Q1FY27 net loss of ₹12.27 lakh, down from ₹15.43 lakh in Q1FY26. Revenue rose 28% YoY to ₹162.42 lakh, but expenses grew faster at ₹175.15 lakh. Other income dropped sharply to ₹0.46 lakh from ₹7.90 lakh. EPS was ₹-0.12.
*this image is generated using AI for illustrative purposes only.
CHD Chemicals Limited reported a net loss of ₹12.27 lakh for the first quarter of FY27 (ended June 30, 2026), compared to a loss of ₹15.43 lakh in the same period of FY26. While the company saw a significant rise in revenue, it failed to convert this top-line growth into profitability due to a sharper increase in operational costs.
CHD Chemicals posted revenue from operations of ₹162.42 lakh in Q1FY27, up from ₹126.89 lakh in Q1FY25. This represents a 28% year-on-year growth in sales. However, total expenses for the quarter stood at ₹175.15 lakh, up from ₹150.22 lakh in the previous year’s corresponding period.
Financial Performance
The company’s earnings per share (basic) were negative at ₹-0.12 per equity share, compared to ₹-0.15 in Q1FY25. The diluted EPS also remained negative at ₹-0.12.
| Metric | Q1FY27 (Unaudited) | Q1FY26 (Unaudited) | Change |
|---|---|---|---|
| Revenue from operations | ₹162.42 lakh | ₹126.89 lakh | +28% |
| Total Expenses | ₹175.15 lakh | ₹150.22 lakh | +17% |
| Net Loss | ₹12.27 lakh | ₹15.43 lakh | -20% |
| EPS (Basic) | ₹-0.12 | ₹-0.15 | Improved |
Other income declined significantly to ₹0.46 lakh in Q1FY27 from ₹7.90 lakh in Q1FY25. Finance costs were contained at ₹1.76 lakh, down from ₹2.67 lakh in the prior year quarter. Employee benefit expenses decreased slightly to ₹3.00 lakh from ₹3.45 lakh.
What the Numbers Show
A key divergence in the data is the sharp decline in other income alongside rising operational losses. In Q1FY25, other income of ₹7.90 lakh offset nearly half of the operational deficit. In Q1FY27, other income fell to just ₹0.46 lakh, meaning the entire net loss is now driven by core operational inefficiencies rather than being partially masked by non-operating gains. This highlights a dependency on operational cost control rather than ancillary income streams.
Board Approval and Audit
The Board of Directors approved the unaudited financial results during its meeting held on August 14, 2026. The results have been reviewed by GAMS & Associates LLP, Chartered Accountants, under Standard on Review Engagement (SRE) 2410. The statement has been prepared in accordance with Indian Accounting Standards (Ind AS).
No shareholder complaints or grievances were received during the period, and none are pending as of June 30, 2026.
Historical Stock Returns for CHD Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -8.57% | -3.61% | -6.98% | -6.80% | -15.04% | -39.85% |
What specific operational cost drivers contributed to the 17% increase in total expenses despite a 28% rise in revenue?
How does management plan to address the sharp decline in other income, which previously offset nearly half of the operational deficit?
Will CHD Chemicals implement new cost-control measures or pricing strategies to convert top-line growth into profitability in Q2FY27?
18
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
